Dual targeting of mortalin and Hsp90 was shown to increase the efficacy of cancer cell death by enhancing p53-mediated apoptosis in hepatocellular carcinoma cells37. The gene discussed is HSP90AB1; the disease is hepatocellular carcinoma.